Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression

Psychosomatic Medicine

Volumn 68, Issue 1, 2006, Pages 1-7

  Forlenza, Michael J ^a   Miller, Gregory E ^b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Comorbidity; Depression; DNA damage; Oxidative damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DNA DAMAGE; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECURRENT DISEASE; SMOKING;

ADULT; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DEPRESSIVE DISORDER; DNA DAMAGE; FEMALE; HUMANS; MALE; OXIDATIVE STRESS;

EID: 33744488777     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000195780.37277.2a     Document Type: Article

References (77)

1. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res 2002;53:849-57.
2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
3. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-15.
4. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003;54:227-40.
5. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
6. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-29.
7. Eaton WW. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 2002;53:903-6.
8. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996;19:1097-102.
9. Penninx B, Guralnik J, Pahor M, Ferrucci L, Cerhan J, Wallace R, Havlik R. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998;90:1888-93.
10. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003;54:283-94.
11. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-82.
12. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001;32:1979-83.
13. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7-21.
14. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70.
15. Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990;11:1447-50.
16. Andreassi MG, Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 2003;13:270-5.
17. Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, Andreassi MG. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002;13:269-74.
18. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;106:927-32.
19. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, Clerico A, Biagini A, Andreassi MG. Evidence for DNA damage in patients with coronary artery disease. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2001;493:23-30.
20. Cooke MS, Evans MD, Dizdaroglu M, Linec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-214.
21. Proteggente AR, England TG, Rehman A, Rice-Evans CA, Halliwell B. Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals. Free Radic Res 2002;36:157-62.
22. Wang D, Kreutzer DA, Essigmann JM. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res 1998;400:99-115.
23. Croteau D, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997;272:25409-12.
24. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992;267:166-72.
25. Kuchino Y, Mori F, Kasai H, Nishimura S, Inoue H, Iwai S, Ohtsuka E. Misreading of 8-hydroxydeoxyguanosine-containing DNA in in vitro DNA replication. Nucleic Acids Symp Ser 1986;157-8.
26. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Ohtsuka E, Nishimura S. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987;327:77-9.
27. Le Page F, Margot A, Grollman AP, Sarasin A, Gentile A. Mutagenicity of a unique 8-oxogaunine in a human Ha-ras sequence in mammalian cells. Carcinogenesis 1995;16:2779-84.
28. Moriya M. Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted GoC? ToA transversions in simian kidney cells. Proc Natl Acad Sci U S A 1993; 90:1122-6.
29. Andreassi MG, Botto N, Colombo MG, Biagini A, Clerico A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? Environ Mol Mutagen 2000;35:265-9.
30. Andreassi MG. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutation Research/Reviews in Mutation Research 2003;543:67-86.
31. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
32. Freedland KE, Skala JA, Carney RM, Raczynski JM, Taylor CB, Mendes de Leon CF, Ironson G, Youngblood ME, Krishnan KR, Veith RC. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 2002;64:897-905.
33. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56.
34. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981;38:381-9.
35. Cooke M, Evan MD, Herbert KE, Lunec J. Urinary 8-oxo-2′- deoxyguanosine - source, significance, and supplements. Free Radic Res 2000;32:381-97.
36. Yin B, Whyatt RM, Perera FP, Randall MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med 1995;18:1023-32.
37. European Standards Committee on Oxidative DNA Damage. Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage. Free Radic Res 2000;32:333-41.
38. Poulsen H, Priemé H, Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer 1998;7:9-16.
39. Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 1993;25:60-70.
40. Lee H, Lim MLR, Lu C, Liu VWS, Fahn H, Zhang C, Nagley P, Wei Y. Concurrent increase of oxidative DNA damage and lipid peroxidation together with mitochondrial DNA mutation in human lung tissues during aging: Smoking enhances oxidative stress on aged tissues. Arch Biochem Biophys 1999;362:309-16.
41. Thompson HJ, Heimendinger J, Haegele A, Sedlacek SM, Gilllette C, O'Neill C, Wolfe P, Corny C. Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis 1999;20:2261-6.
42. Van Zeeland AA, de Groot AjL, Hall J, Donato F. 8-Hydroxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat Res 1999;439:249-57.
43. Asami S, Hirano T, Yamaguchi R, Itoh H, Kasai H. Reduction of 8-hydroxyguanine in human leukocyte DNA by physical exercise. Free Radic Res 1998;29.
44. Hartmann A, Pfuhler S, Dennog C, Germadnik D, Pilger A, Speit G. Exercise-induced DNA effects in human leukocytes are not accompanied by increased formation of 8-hydroxy-2′-deoxyguanosine or induction of micronuclei. Free Radic Biol Med 1998;24:245-51.
45. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxyguanosine, in a central site of the human lung. Carcinogenesis 1997;18:1763-6.
46. Okamura K, Doi T, Hamada K, Sakurai M, Yoshioka Y, Mitsuzono R, Migata T, Sumida S, Sugawa-Katayama Y. Effect of repeated exercise on urinary 8-hydroxy-deoxyguanosine excretion in humans. Free Radic Res 1997;26:507-14.
47. Asami S, Hirano T, Yamaguchi R, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 1996;56.
48. Nakajima M, Takeuchi T, Takeshita T, Morimoto K. 8-hydroxydeoxyguanosine in human leukocyte DNA and daily health practice factors: effects of individual alcohol sensitivity. Environ Health Perspect 1996;104:1336-8.
49. Inoue T, Mu Z, Sumikawa K, Adachi K, Okochi T. Effects of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from human leukocytes. Jpn J Cancer Res 1993;84:720-5.
50. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K Poulsen HE. Oxidative damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking gender and body mass index. Carcinogenesis 1992;13:2241-7.
51. Hsu TC FC. The role of ethanol in oncogenesis of the upper aerodigestive tract; inhibition of DNA repair. Anticancer Res 1991;11:1995-8.
52. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KRR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, for the Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
53. Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res 2001;92:367-76.
54. Irie M, Asami S, Nagata S, Miyata M, Kasai H. Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health 2001;74:153-7.
55. Irie M, Asami S, Ikeda M, Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003;311:1014-8.
56. Krishnan KRR, Delong M, Kraemer H, Carney R, Spiegel D, Gordon C, McDonald W, Dew MA, Alexopoulos G, Buckwalter K. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 2002;52:559-88.
57. Miller GE, Cohen S, Herbert TB. Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med 1999;61:850-60.
58. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86.
59. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-85.
60. Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol 2005;95:317-21.
61. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83.
62. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-44.
63. Simic MG. DNA markers of oxidative processes in vivo: relevance to carcinogenesis and anticarcinogenesis. Cancer Res 1994;54:1918s-23s.
64. Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AF, Cochrane CG, Dizdaroglu M. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest 1989;84:1644-9.
65. Shacter E, Beecham EJ, Covey JM, Kohn KW, Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 1988;9:2297-304.
66. Aust AE, Eveleigh JF. Mechanisms of DNA oxidation. Proc Soc Exp Biol Med 1999;222:246-52.
67. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med 1985;8:311-20.
68. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 2001;947:271-93.
69. Welch RW, Turley E, Sweetman SF, Kennedy G, Collins AR, Dunne A, Livingstone MBE, McKenna PG, McKelvey-Martin vJ, Strain JJ. Dietary antioxidant supplementation & DNA damage in smokers and nonsmokers. Nutr Cancer 1999;34:167-72.
70. Wachsman JT. The beneficial effects of dietary restriction: reduced oxidative damage and enhanced apoptosis. Mutat Res 1996;350:25-34.
71. Green MH, Lowe JE, Waugh AP, Aldridge KE, Cole J, Arlett CF. Effects of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res 1994;316:91-102.
72. Vega-Lopez S, Devaraj S, Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med 2004;52:24-32.
73. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-6.
74. Verhagen H, Poulsen HE, Loft S, van Poppel G, Willems MI, van Bladeren PJ. Reduction of oxidative DNA-damage in humans by Brussels sprouts. Carcinogenesis 1995;16:969-70.
75. Miller AH. Cytokines and sickness behavior: implications for cancer care and control. Brain Behav Immun 2003;17:132-4.
76. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999;4:317-27.
77. Capuron L, Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 2003;17:119-24.